Matrine Promotes Human Myeloid Leukemia Cells Apoptosis Through Warburg Effect Mediated by Hexokinase 2

被引:36
作者
Lin, Guibin [1 ]
Wu, Yangzhe [2 ,3 ]
Cai, Fengtao [1 ]
Li, Zhen [2 ,3 ]
Su, Shixin [2 ,3 ]
Wang, Jian [1 ]
Cao, Jialin [1 ]
Ma, Lingdi [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp, Peoples Hosp Huizhou 3, Lab Ctr, Huizhou, Peoples R China
[2] Jinan Univ, Biomed Translat Res Inst, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[3] Jinan Univ, Sch Pharm, Guangzhou, Guangdong, Peoples R China
关键词
matrine; leukemia; hexokinase; 2; glycolysis; apoptosis; CANCER; METABOLISM; LONIDAMINE; GLYCOLYSIS; MYC; INHIBITION; INCREASES;
D O I
10.3389/fphar.2019.01069
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Matrine, an alkaloid compound isolated from the medicinal plant Sophora flavescens, inhibits many types of cancer proliferation. However, the precise mechanism of the matrine antihuman chronic myeloid leukemia remains unclear. In this study, we showed that matrine significantly inhibited the cell proliferation and induced apoptosis by regulating Warburg effect through controlling hexokinases 2 (HK2) expression in myeloid leukemia cells. Interestingly, matrine inhibited the expression of HK2 mediated by reduction in c-Myc binding to HK2 gene intron and led to downregulation of HK2, which upregulated proapoptotic protein Bad and then induced apoptosis. We further demonstrated that matrine could synergize with lonidamine, an inhibitor of HK2, for the treatment of myeloid leukemia, both in vitro and in vivo. Taken together, our findings reveal that matrine could promote human myeloid leukemia cells apoptosis via regulating Warburg effect by controlling HK2.
引用
收藏
页数:11
相关论文
共 38 条
[1]   Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer [J].
Akins, Nicholas S. ;
Nielson, Tanner C. ;
Le, Hoang V. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (06) :494-504
[2]   Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment [J].
Arrigoni, Elena ;
Del Re, Marzia ;
Galimberti, Sara ;
Restante, Giuliana ;
Rofi, Eleonora ;
Crucitta, Stefania ;
Barate, Claudia ;
Petrini, Mario ;
Danesi, Romano ;
Di Paolo, Antonello .
STEM CELLS TRANSLATIONAL MEDICINE, 2018, 7 (03) :305-314
[3]   Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia [J].
Boag, J. M. ;
Beesley, A. H. ;
Firth, M. J. ;
Freitas, J. R. ;
Ford, J. ;
Hoffmann, K. ;
Cummings, A. J. ;
de Klerk, N. H. ;
Kees, U. R. .
LEUKEMIA, 2006, 20 (10) :1731-1737
[4]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[5]   Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study [J].
De Lena, M ;
Lorusso, V ;
Latorre, A ;
Fanizza, G ;
Gargano, G ;
Caporusso, L ;
Guida, M ;
Catino, A ;
Crucitta, E ;
Sambiasi, D ;
Mazzei, A .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (03) :364-368
[6]   MYC and tumor metabolism: chicken and egg [J].
Dejure, Francesca R. ;
Eilers, Martin .
EMBO JOURNAL, 2017, 36 (23) :3409-3420
[7]   Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin (vol 9, 2018) [J].
DeWaal, Dannielle ;
Nogueira, Veronique ;
Terry, Alexander R. ;
Patra, Krushna C. ;
Jeon, Sang-Min ;
Guzman, Grace ;
Au, Jennifer ;
Long, Christopher P. ;
Antoniewicz, Maciek R. ;
Hay, Nissim .
NATURE COMMUNICATIONS, 2018, 9
[8]   Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors [J].
Di Cosimo, S ;
Ferretti, G ;
Papaldo, P ;
Carlini, P ;
Fabi, A ;
Cognetti, F .
DRUGS OF TODAY, 2003, 39 (03) :157-173
[9]   Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: Results from a multicenter prospective randomized trial [J].
Dogliotti, L ;
Berruti, A ;
Buniva, T ;
Zola, P ;
Bau, MG ;
Farris, A ;
Sarobba, MG ;
Bottini, A ;
Alquati, P ;
Deltetto, F ;
Gosso, P ;
Monzeglio, C ;
Moro, G ;
Sussio, M ;
Perroni, D .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1165-1172
[10]  
FLORIDI A, 1981, JNCI-J NATL CANCER I, V66, P497